Chlamydial Pneumonia

Chlamydia pneumonia is an acute inflammation of the lungs caused by Chlamydia pneumoniae infection. Chlamydia pneumoniae can lead to the destruction of the mucosal structure of the respiratory tract and induce infections by other pathogens. The symptoms of patients are usually mild, mainly manifested as sore throat, runny nose, fever, cough, etc. The course of the disease can last as long as 1-2 months, and maybe accompanied by symptoms such as pharyngitis, laryngitis, and sinusitis. Chlamydia pneumonia is contagious and spreads mainly through droplets. There is a small-scale epidemic in semi-enclosed environments, such as homes, schools, military, and densely populated areas.

Diagnosis of Chlamydial Pneumonia

Chlamydia pneumonia can be diagnosed by the following methods:

• Blood routine. The white blood cells in the peripheral blood are generally normal or slightly higher, the erythrocyte sedimentation rate and the C-reactive protein increase.
• Serological examination. Chlamydia pneumoniae infection can stimulate the body to produce antibodies, and the presence of Chlamydia pneumoniae infection can be confirmed by detecting the antibody level in the patient. If there is a sharp increase in IgM and IgG in both the acute phase and the recovery phase, the diagnosis can be confirmed. The serological examination is a commonly used examination method, including direct immunofluorescence, enzyme-linked immunosorbent assay and other techniques.
• Nucleic acid amplification testing. If the nucleic acid of Chlamydia pneumoniae can be detected from oropharyngeal swabs and other samples by PCR and other methods, it has important reference significance for early rapid diagnosis.
• Isolation and cultivation of pathogens. Collecting samples of patients' oropharyngeal swabs for isolation, culture and identification of pathogens is the gold standard for the diagnosis of Chlamydial pneumonia. However, the pathogen culture cycle is long and the operation is complicated, so it is generally only used for laboratory research.
• Imaging examination. The chest X-ray film initially showed unilateral alveolar infiltration, and later it may progress to bilateral interstitial and alveolar infiltration.

Advantages of Our Products

Creative Biogene's diagnostic products mainly use enzyme-linked immunoassay technology to determine IgG, IgA and IgM antibodies against Chlamydia pneumoniae in serum and plasma. The total incubation time of our kit is short, the operation is simple, the accurate result can be obtained quickly, and the sensitivity is high, which is greater than 95%.

Creative Biogene has a professional team of experts who developed quality Chlamydia pneumonia diagnostic products. Our products are competitive in the market due to their reasonable price and high quality, which can help you solve the diagnosis problem quickly. We look forward to working with you for your cooperation.

Please contact us for more details.

Reference

1. Opota O, et al. (2017). "Methods for Real-Time PCR-Based Diagnosis of Chlamydia pneumoniae, Chlamydia psittaci, and Chlamydia abortus Infections in an Opened Molecular Diagnostic Platform. " Methods in Molecular Biology. 1616:171-181.